Integrated Filing — IndAS



General information about company

Scrip Code 500875
NSE Symbol ITC
MSEI Symbol NOTLISTED
ISIN INE154A01025
Name of company ITC Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 21-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 07-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 21-05-2026   12:35:00
End date and time of board meeting 21-05-2026   15:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 23,82,148.00 89,91,333.00
Other income 58,515.00 2,42,580.00
Total income 24,40,663.00 92,33,913.00
2 Expenses
(a) Cost of materials consumed 6,66,003.00 26,27,233.00
(b) Purchases of stock-in-trade 1,81,873.00 8,82,601.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (2,72,042.00) (2,55,046.00)
(d) Employee benefit expense 1,74,710.00 6,78,150.00
(e) Finance costs 2,918.00 8,517.00
(f) Depreciation, depletion and amortisation expense 42,195.00 1,71,053.00
(f) Other Expenses
1 Excise Duty 5,99,680.00 11,04,493.00
2 Other Expenses 3,39,501.00 12,22,111.00
Total other expenses 9,39,181.00 23,26,604.00
Total expenses 17,34,838.00 64,39,112.00
3 Total profit before exceptional items and tax 7,05,825.00 27,94,801.00
4 Exceptional items (2,520.00) (29,170.00)
5 Total profit before tax 7,03,305.00 27,65,631.00
6 Tax expense
7 Current tax 1,80,600.00 6,41,297.00
8 Deferred tax (10,312.00) 60,227.00
9 Total tax expenses 1,70,288.00 7,01,524.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 5,33,017.00 20,64,107.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 13,957.00 37,708.00
16 Total profit (loss) for period 5,46,974.00 21,01,815.00
17 Other comprehensive income net of taxes (79,125.00) (64,329.00)
18 Total Comprehensive Income for the period 4,67,849.00 20,37,486.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 5,38,797.00 20,68,947.00
Total profit or loss, attributable to non-controlling interests 8,177.00 32,868.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 4,59,650.00 20,04,727.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 8,199.00 32,759.00
21 Details of equity share capital
Paid-up equity share capital 1,25,295.00 1,25,295.00
Face value of equity share capital 1 1
27 Details of debt securities
22 Reserves excluding revaluation reserve 71,25,435.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 4.3 16.52
Diluted earnings (loss) per share from continuing operations 4.3 16.51
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 4.3 16.52
Diluted earnings (loss) per share from continuing and discontinued operations 4.3 16.51
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. ‘Revenue from operations’ includes ‘Gross Revenue from sale of products and services’ and ‘Other operating revenue’. 2. ‘Purchase of stock-in-trade’ should be read as ‘Purchase of Stock-in-Trade and Biological Assets’. 3. ‘Changes in inventories of finished goods, work-in-progress and stock-in-trade’ should be read as ‘Changes in inventories of finished goods, Stock-in-Trade, work-in-progress, intermediates and Biological Assets’. 4. ‘Depreciation, depletion and amortisation expense’ should be read as ‘Depreciation and amortization expense’. NOTES TO STATEMENT OF AUDITED CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND TWELVE MONTHS ENDED 31.03.2026 1. The audited Consolidated Financial Results and Segment Results were reviewed by the Audit Committee, and approved by the Board of Directors of the Company at its meeting held on 21st May, 2026. 2. The continuing significant brand building costs covering a range of personal care and branded packaged food products are reflected under 'Other expenses' stated above and in Segment Results under 'FMCG-Others'. 3. 5,08,460 Ordinary Shares of Re. 1/- each were issued and allotted under the Company’s Employee Stock Option Schemes during the quarter ended 31st March, 2026. Consequently, the issued and paid-up Share Capital of the Company stands increased to Rs. 1252,94,68,231/- as on 31st March, 2026. 4. Exceptional Items of Continuing Operations for the twelve months ended 31st March, 2026 of Rs. 291.70 Crores represents : a) estimated one-time impact on recognition of past service cost of Rs. 379.78 Crores with respect to increase in liability of gratuity and compensated absences, primarily arising due to change in definition of wages pursuant to notifications issued by the Ministry of Labour & Employment dated 21st November, 2025 bringing into force the provisions of the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020 (collectively referred to as the New Labour Codes). The Group continues to monitor the finalisation of rules by the Central and State Governments and clarifications from the Government on other aspects of the New Labour Codes and will account for such developments as needed. b) receipt of Rs. 88.08 Crores on final settlement of the insurance claim towards leaf tobacco stocks, which were destroyed due to fire at a third party owned warehouse in an earlier year. 5. The amalgamation of Sresta Natural Bioproducts Private Limited (‘Sresta’) and Wimco Limited (‘Wimco’), wholly owned subsidiaries, with the Company was approved by the Board of Directors on 1st August, 2025. The Hon’ble National Company Law Tribunal (‘NCLT’), Kolkata Bench, vide Order dated 20th March, 2026, and NCLT, Hyderabad Bench, vide Order dated 16th April, 2026, have approved the said amalgamation and certified copies of the Orders have been filed with the Registrar of Companies, West Bengal and Telangana, respectively, on 7th May, 2026. Since all the requisite formalities have been completed, the aforesaid amalgamation has been given effect to in these Financial Results from the respective Appointed Dates i.e. 1st April, 2025 for Wimco and 13th June, 2025 for Sresta. Accordingly, the two subsidiaries of Sresta viz., Sresta Global FZE, UAE and Fyve Elements LLC, USA, have become direct wholly owned subsidiaries of the Company. The fair value of assets and liabilities acquired have been recorded at their provisional acquisition date fair values in accordance with Ind AS 103 - Business Combinations. The financial results of the Group and 'FMCG-Others' segment include those of Sresta and its subsidiaries from 13th June, 2025 and consequently are not comparable with previous periods. 6. Consequent to expiry of the GST Compensation Cess, the Government of India increased GST and Central Excise duty on cigarettes with effect from 1st February, 2026. In accordance with Ind AS 115 - Revenue from Contracts with Customers and Schedule Ill to the Companies Act, 2013, GST and GST Compensation Cess are excluded from Gross Revenue from sale of products, whereas Excise duty is not excluded. Consequently, the Gross Revenue from sale of products and services & Excise duty for the quarter and year ended 31st March, 2026 and value of inventory as at 31st March, 2026 reflect the impact of sharp increase in Excise duty and are not strictly comparable with those of the previous periods. 7. The Board of Directors of the Company have recommended to the Members for their approval, Final Dividend of Rs. 8.00 per Ordinary Share of Re. 1/- each for the financial year ended 31st March, 2026 (previous year: Final Dividend of Rs 7.85 per Ordinary Share). Together with the Interim Dividend of Rs. 6.50 per Ordinary Share (previous year: Rs. 6.50 per Ordinary Share) paid on 27th February, 2026, the total Dividend for the financial year ended 31st March, 2026 amounts to Rs. 14.50 per Ordinary Share (previous year: Rs.14.35 per Ordinary Share). Total cash outflow on account of Dividend (including Interim Dividend of Rs. 8144.00 Crores paid in February, 2026) will be Rs. 18167.57 Crores (previous year: Rs. 17956.69 Crores). The Record Date fixed for the purpose of determining entitlement of the Members for the Final Dividend is Wednesday, 27th May, 2026 and such Dividend, if declared, will be paid between Friday, 24th July, 2026 and Wednesday, 29th July, 2026 to those Members entitled thereto. 8. The 115th Annual General Meeting of the Company has been convened for Thursday, 23rd July, 2026. 9. This statement is as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 17,47,120.00
Capital work-in-progress 1,49,941.00
Investment property 30,336.00
Goodwill 99,329.00
Other intangible assets 3,17,366.00
Intangible assets under development 10,247.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 5,28,824.00
Non-current financial assets
Non-current investments 12,08,955.00
Trade receivables, non-current 0.00
Loans, non-current 487.00
Other non-current financial assets
1 Other financial assets 34,322.00
Total of other non-current financial assets 34,322.00
Total non-current financial assets 12,43,764.00
Deferred tax assets (net) 15,518.00
Other non-current assets
1 Right-of-use assets 50,102.00
2 Other non-current assets 1,08,845.00
3 Income Tax Assets (net) 7,005.00
Total of other non-current assets 1,65,952.00
Total non-current assets 43,08,397.00
2 Current assets
Inventories 18,62,296.00
Current financial asset
Current investments 20,75,064.00
Trade receivables, current 3,92,286.00
Cash and cash equivalents 64,346.00
Bank balance other than cash and cash equivalents 2,36,533.00
Loans, current 852.00
Other current financial assets
Total of other current financial assets 2,36,134.00
Total current financial assets 30,05,215.00
Current tax assets (net) 0.00
Other current assets
1 Biological assets other than bearer plants 24,969.00
2 Other current assets 1,78,361.00
Total of other current assets 2,03,330.00
Total current assets 50,70,841.00
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 93,79,238.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,25,295.00
Other equity 71,25,435.00
Total equity attributable to owners of parent 72,50,730.00
Non controlling interest 36,572.00
Total equity 72,87,302.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 6,000.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease liabilities 14,086.00
2 Other financial liabilities 51,040.00
Total of other non-current financial liabilities 65,126.00
Total non-current financial liabilities 71,126.00
Provisions, non-current 38,943.00
Deferred tax liabilities (net) 3,08,962.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 4,178.00
Total of other non-current liabilities 4,178.00
Total non-current liabilities 4,23,209.00
Current liabilities
Current financial liabilities
Borrowings, current 2,12,622.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 35,013.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 5,28,942.00
Total Trade payable 5,63,955.00
Other current financial liabilities
1 Other current financial liabilities 2,09,915.00
2 Lease liabilities 7,198.00
Total of other current financial liabilities 2,17,113.00
Total current financial liabilities 9,93,690.00
Other current liabilities 5,03,764.00
1 Other current liabilities 5,03,764.00
Total of other current liabilities 5,03,764.00
Provisions, current 42,391.00
Current tax liabilities (Net) 1,28,882.00
Deferred government grants, Current 0.00
Total current liabilities 16,68,727.00
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 20,91,936.00
Total equity and liabilites 93,79,238.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 FMCG - Cigarettes 11,95,172.00 40,60,100.00
2 FMCG - Others 6,35,241.00 24,32,155.00
3 Agri Business 3,16,665.00 20,78,733.00
4 Paperboards, Paper & Packaging 2,22,861.00 8,76,858.00
5 Others 1,30,526.00 5,03,623.00
Total Segment Revenue 25,00,465.00 99,51,469.00
Less: Inter segment revenue 1,37,896.00 10,25,648.00
Revenue from operations 23,62,569.00 89,25,821.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 FMCG - Cigarettes 5,79,730.00 22,24,562.00
2 FMCG - Others 52,578.00 1,81,182.00
3 Agri Business 20,011.00 1,58,424.00
4 Paperboards, Paper & Packaging 23,250.00 75,406.00
5 Others 14,499.00 67,040.00
Total Profit before tax 6,90,068.00 27,06,614.00
i. Finance cost 2,918.00 8,517.00
ii. Other Unallocable Expenditure net off Unallocable income (30,112.00) (1,05,242.00)
Profit before tax 7,17,262.00 28,03,339.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 FMCG - Cigarettes 13,99,556.00 13,99,556.00
2 FMCG - Others 13,35,944.00 13,35,944.00
3 Agri Business 7,79,223.00 7,79,223.00
4 Paperboards, Paper & Packaging 10,02,121.00 10,02,121.00
5 Others 2,99,745.00 2,99,745.00
Total Segment Asset 48,16,589.00 48,16,589.00
Un-allocable Assets 45,62,649.00 45,62,649.00
Net Segment Asset 93,79,238.00 93,79,238.00
4 Segment Liabilities
Segment Liabilities
1 FMCG - Cigarettes 5,74,963.00 5,74,963.00
2 FMCG - Others 3,08,915.00 3,08,915.00
3 Agri Business 1,78,443.00 1,78,443.00
4 Paperboards, Paper & Packaging 1,39,522.00 1,39,522.00
5 Others 1,23,117.00 1,23,117.00
Total Segment Liabilities 13,24,960.00 13,24,960.00
Un-allocable Liabilities 7,66,976.00 7,66,976.00
Net Segment Liabilities 20,91,936.00 20,91,936.00
Disclosure of notes on segments Textual Information(2)



Text Block

Textual Information(2) 1. ‘Revenue from operations’ should be read as ‘Gross Revenue from sale of products and services’. 2. ‘Other Unallocable Expenditure net off Unallocable income’ should be read as ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’. 3. In case of 3 months ended 31.03.2026, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (186.75) Crores, Exceptional Items* of Rs. 25.20 Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 139.57 Crores. 4. In case of 12 months ended 31.03.2026, ‘Other Unallocable Expenditure net off Unallocable income’ includes ‘Other un-allocable (income) net of un-allocable expenditure (Refer Note)’ of Rs. (967.04) Crores, Exceptional Items* of Rs. 291.70 Crores and Share of Profit / (Loss) of associates and joint ventures of Rs. 377.08 Crores. # The figures of 3 months ended 31.03.2026 and corresponding 3 months ended 31.03.2025 are the balancing figures between the audited figures in respect of the full financial year and the year to date figures upto the third quarter of the respective financial years, which were subjected to limited review. * Refer note 4 to the Consolidated Financial Results. Note: As stock options and stock appreciation rights are granted to align the interests of employees with those of shareholders and also to attract and retain talent for the Group as a whole, the charge thereof do not form part of the segment performance reviewed by the Corporate Management Committee.



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified to profit or loss (98,180.00) (83,527.00)
Total Amount of items that will not be reclassified to profit and loss (98,180.00) (83,527.00)
2 Income tax relating to items that will not be reclassified to profit or loss (13,337.00) (11,165.00)
3 Amount of items that will be reclassified to profit and loss
1 Items that will be reclassified to profit or loss 4,300.00 4,492.00
Total Amount of items that will be reclassified to profit and loss 4,300.00 4,492.00
4 Income tax relating to items that will be reclassified to profit or loss (1,418.00) (3,541.00)
5 Total Other comprehensive income (79,125.00) (64,329.00)



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 27,65,631.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 8,517.00
Adjustments for decrease (increase) in inventories (3,30,625.00)
Adjustments for decrease (increase) in trade receivables, current 46,808.00
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 0.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 7,589.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 1,71,053.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 7.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (2,557.00)
Adjustments for dividend income 1,516.00
Adjustments for interest income 1,46,223.00
Adjustments for share-based payments 12,800.00
Adjustments for fair value losses (gains) (86,001.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 38,309.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,81,839.00)
Net cash flows from (used in) operations 24,83,792.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 6,37,361.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 18,46,431.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 1.00
Cash flows used in obtaining control of subsidiaries or other businesses 18,309.00
Other cash receipts from sales of equity or debt instruments of other entities 65,73,666.00
Other cash payments to acquire equity or debt instruments of other entities 68,17,284.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 5,045.00
Purchase of property, plant and equipment 2,18,289.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 953.00
Cash receipts from repayment of advances and loans made to other parties 1,331.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 4,543.00
Interest received 91,701.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,46,474.00
Net cash flows from (used in) investing activities (2,32,074.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 40,485.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 2,12,050.00
Repayments of borrowings 10,531.00
Payments of lease liabilities 6,824.00
Dividends paid 18,27,202.00
Interest paid 8,170.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (14,520.00)
Net cash flows from (used in) financing activities (16,14,712.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (355.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (355.00)
Cash and cash equivalents cash flow statement at beginning of period 62,238.00
Cash and cash equivalents cash flow statement at end of period 61,883.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S R B C & CO LLP Yes 28-02-2029